Ipamorelin Mechanism of Action Detailed: Comparison Table
Ipamorelin GHS-R1a (selective) Pulsatile, physiological amplitude None Isolated GH studies, metabolic research, bone density trials GHRP-6 GHS-R1a + hypothalamic ghrelin receptors Pulsatile, moderate amplitude Moderate (40–60% increase) Strong appetite stimula
This comparison does not assign a generated winner or score.
- Ipamorelin
- GHS-R1a (selective)
- Pulsatile, physiological amplitude
- None
- Isolated GH studies, metabolic research, bone density trials
- GHRP-6
- GHS-R1a + hypothalamic ghrelin receptors
- Pulsatile, moderate amplitude
- Moderate (40–60% increase)
- Strong appetite stimulation
- Appetite regulation studies, cachexia models
- Hexarelin
- GHS-R1a + CD36 receptor
- Pulsatile, high amplitude
- High (200%+ increase)
- Moderate
- Cardiac function research, not recommended for GH isolation
- GHRH (sermorelin)
- GHRH receptor
- Pulsatile, amplitude varies with endogenous GHRH reserve
- Studies requiring GHRH pathway activation, not ghrelin pathway
- CJC-1295
- GHRH receptor (DAC-extended)
- Sustained elevation (not pulsatile)
- Long-duration GH elevation studies, not pulse-dependent research
- Bottom Line
- Ipamorelin offers the cleanest GHS-R1a activation for studying GH's isolated effects without cortisol, prolactin, or appetite confounds. Critical for metabolic and anabolic research.